Handok, Fresenius Kabi to join forces in oncology field

Published: 2011-03-15 06:57:00
Updated: 2011-03-15 06:57:00
Handok Pharm said Friday it has signed an exclusive distribution agreement with Fresenius Kabi Korea to sell the latter’s four oncology products, including irinotecan and oxaliplatin, here in Korea.

Under the agreement, Handok plans to set up its new oncology department and introduce Fresenius...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.